# To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.

Study · id `cardio:ct-nct07403565` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07403565](<https://clinicaltrials.gov/study/NCT07403565>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07403565

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

## Technical summary

Registry record NCT07403565. Randomized; no masking; primary purpose treatment. Start 2025-06-14 (actual); primary completion 2025-11-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 161 participants (enrolled count; ClinicalTrials.gov record NCT07403565, source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)
- Started: 2025-06-14 (actual) (ClinicalTrials.gov record NCT07403565, source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)
- Primary completion: 2025-11-08 (actual) (ClinicalTrials.gov record NCT07403565, source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)
- Completion: 2025-12-03 (actual) (ClinicalTrials.gov record NCT07403565, source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07403565, source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07403565-2026-02-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.
- Condition: Type 1 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Insulin Patch Pump System
- Intervention (Device): Minimed 700
- Lead sponsor: Suzhou Hechun Medical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 028fb88eed34b7cdd6626bf5f5972320a4891006b7c5750a167fabe6b9441aeb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
